3 not yet recruiting, 3 recruiting, 1 active not recruiting. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Interstitial Lung Disease Due to Systemic Disease: new trials by email Literature Review of Interstitial Lung Disease Due to Systemic Disease trials Research Report on Interstitial Lung Disease Due to Systemic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation Progressive Walking Exercise Programme, Real-time air quality information and guidance - Cardiovascular Disease, Asthma | Not applicable | Not yet recruiting | University of Leicester | 80 | 2026-10-01 | 2026-10-05 |
| The King's Brief Lnterstitial Lung Disease Questionnaire patient reported outcome measures - Interstitial Lung Disease Due to Systemic Disease | Not yet recruiting | Pamukkale University | 45 | 2026-07-05 | 2026-07-13 | |
| Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative) Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease in Patients With Rheumatoid Arthritis | Not yet recruiting | St. Lawrence Health System | 10 | 2025-11-01 | 2025-10-15 | |
| Platform Clinical Study for Conquering Scleroderma Amlitelimab, BI 1015550 (Nerandomilast), Placebo - Interstitial Lung Disease Due to Systemic Disease, Scleroderma | Phase 2 | Recruiting | Scleroderma Research Foundation, Inc. | 400 | 2024-04-15 | 2026-08-18 |
| Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency Fisetin, Placebo - Common Variable Immunodeficiency, Interstitial Lung Disease Due to Systemic Disease | Phase 2 | Active not recruiting | Avni Joshi | 20 | 2023-04-12 | 2026-06-30 |
| Western Sweden Systemic Sclerosis Project No Intervention: Observational Cohort - Scleroderma, Systemic, Fibrosis; Skin | Recruiting | Sahlgrenska University Hospital | 150 | 2022-06-20 | 2026-01-15 | |
| Registry of Autoimmune Interstitial Lung Disease Multidisciplinary aproach - Interstitial Lung Disease Due to Systemic Disease | Recruiting | EPIMAR registry | 1000 | 2022-04-10 | 2022-05-06 |
Scleroderma, Systemic (3) · Lung Diseases, Interstitial (2) · Arthritis, Rheumatoid (1) · Asthma (1) · Cardiovascular Diseases (1) · Common Variable Immunodeficiency (1) · Connective Tissue Diseases (1) · Coronary Disease (1) · Fibrosis (1) · Heart Failure (1) · Motor Activity (1) · Pulmonary Disease, Chronic Obstructive (1) · Pulmonary Fibrosis (1) · Scleroderma, Diffuse (1)
Lung Diseases (4) · Respiratory Tract Diseases (4) · Immune System Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Connective Tissue Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arthritis (1) · Autoimmune Diseases (1) · Behavior (1) · Bronchial Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Heart Diseases (1)
BI 1015550 (1) · Counseling (1) · Patient Reported Outcome Measures (1) · fisetin (1)
Avni Joshi (1) · EPIMAR registry (1) · Pamukkale University (1) · Sahlgrenska University Hospital (1) · Scleroderma Research Foundation, Inc. (1) · St. Lawrence Health System (1) · University of Leicester (1)
United States (3) · Argentina (1) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Andre Ng, Ph.D, MD (1) · Avni Joshi, MD, MS (1) · Florencia Vivero, MD (1) · Kevin O'Shea (1)